key: cord-0707379-eqtzmd87
authors: Vázquez‐Osorio, Igor; Rocamonde, Lucía; Treviño‐Castellano, Mercedes; Vázquez‐Veiga, Hugo; Ginarte, Manuel
title: Pseudo‐chilblain lesions and COVID‐19: a controversial relationship
date: 2021-02-09
journal: Int J Dermatol
DOI: 10.1111/ijd.15422
sha: 9a83b2c8eab049a69f4002334965a51e330730e8
doc_id: 707379
cord_uid: eqtzmd87

nan

tions, including acral lesions similar to chilblains. 1 News of the possible association between chilblains and COVID-19 in the media and on social networks generated consternation among the general public in Spain and a considerable increase in medical consultations. A direct association between pseudo-chilblains and COVID-19, however, has not been unequivocally demonstrated, as microbiologically confirmed SARS-CoV-2 infection has been reported in very few cases. 2, 3 We had the opportunity to study 14 patients with pseudochilblain lesions during the state of emergency declared in Spain on March 14, 2020 (Fig. 1) . Their mean age was 13.28 years (range, 7-20 years). The clinical and analytical data are summarized in Table 1. PCR for SARS-CoV-2 was negative in 100% of patients.

Serological testing (chemiluminescent immunoassay, Vircell, Spain, and enzyme-linked immune assay, Euroimmun, Germany) revealed two positive cases: a 13-year-old girl with a positive result for SARS-CoV-2 IgG antibodies and a 17-yearold boy with a positive result for SARS-CoV-2 IgA and IgM antibodies. Additional tests were performed to rule out other possible causes of acrocyanosis (Table 1 ). The only significant pathological finding was cryoglobulinemia in three patients, including the 17-year-old boy with SARS-CoV-2 IgA and IgM antibodies. All the patients progressed favorably.

Chilblains represent an inflammatory skin reaction resulting from a maladaptive vascular response to very cold weather. 4 The accumulation of cases several weeks after the peak in COVID-19 cases in Spain raised questions about a possible association with SARS-CoV-2. Pseudo-chilblain lesions have been reported as a late manifestation of COVID-19 and have been mostly observed in young patients with mild symptoms. 1, 4 However, a causative link between pseudo-chilblain lesions and SARS-CoV-2 infection has not been proven. It has been suggested that immune-mediated inflammation or microthrombosis might have a role in their pathogenesis. 4 Another theory is that SARS-CoV-2 infection might induce the expression of type 1 interferon, leading to microangiopathic changes. 5 Hubiche et al 3 demonstrated a significantly higher INF-alpha response in patients with pseudo-chilblain lesions. They suggested that the type of immune response is a key factor explaining the different clinical manifestations of SARS-CoV-2 infection. 3 The patient in our series who tested positive for SARS-CoV-2

IgM antibodies also tested positive for cryoglobulins, which could also have a pathogenic role, as has been observed in patients with hepatitis C virus infection. 6 

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

Are chilblain-like acral skin lesions really indicatative of COVID-19? A prospective study and literature review

Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic

Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries

COVID-19) infection-induced chilblains: a case report with histopathological findings

Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis